Custom Search


Tuesday 31 July 2007

Recordati signs deal with Meda to sell hypertensive drug in Spain

By: Thomson Financial

Recordati SpA, the Italian pharmaceutical company, said it has signed a long-term agreement with Meda to market a new antihypertensive drug in Spain.

Meda, which is based in Sweden, already has marketing rights for the drug in Germany and Scandinavia.

The drug combines lercanidipine and enalapril, two treatments used for high blood pressure.

View the original article

Use of this site is subject to the following terms of use